Viral Hepatitis C - Enzo Biochem Initiates Phase II Trial of Immunomodulatory Compound ...

Enzo Biochem Initiates Phase II Trial of Immunomodulatory Compound ...
Genetic Engineering News, NY - Mar 14, 2006... of its proprietary gene medicine for HIV-1 infection and its proprietary immune regulation medicines for hepatitis B and hepatitis C infection and for Crohn's ...

Human Genome Sciences Reports Positive Interim Results of Phase 2 ...
PR Newswire (press release), NY - Mar 14, 2006... Human Genome Sciences is developing Albuferon for use in the treatment of chronic hepatitis C. Hepatitis C infection is an inflammation of the liver caused by ...

The needle-exchange program: This is 'success'?
Pittsburgh Tribune-Review, PA - Mar 23, 2006... And since determining when the hepatitis C infection occurred is difficult, quantifying the program's effectiveness is nearly impossible. ...

Stocks to Watch: Peregrine Pharmaceuticals
New Age Media Concepts (press release) - Mar 30, 2006Their portfolio consist of Tarvacin Anti-Viral is in Phase I studies for hepatitis C infection pre-clinical studies in influenza, Tarvacin Anti-Cancer is in a ...

Needle exchange coming to town
KSBY, CA - Mar 9, 2006... and running. An exchange center can lower HIV and Hepatitis C infection rates, which are transmitted through sharing needles. The ...